|
 |
Nasdaq to delist Alpharetta's AtheroGenics
AtheroGenics Inc. (NASDAQ: AGIX) today reported that it received notification from the Nasdaq Stock Market indicating that the staff of the Nasdaq Stock Market had determined that the company's common stock should be delisted from the Nasdaq Global Market in light of its filing under Chapter 11 of the U....More |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
